Skip to main content

Author Instructions

Author Instructions

About the journal: Wound Management & Prevention (WMP) (formerly Ostomy Wound Management), is a peer-reviewed, multi- and interdisciplinary journal dedicated to informing the practice, advancing the science, and improving the evidence base of all aspects of wound, continence, ostomy, and skin care. The name was changed to reflect the evolving focus in wound care on prevention as well as on management that may/may not achieve healing. WMP is published monthly. 

WMP is indexed in MEDLINE and the Cumulative Index to Nursing and Allied Health (CINAHL) and included in the Thomson Reuters Scientific Database and the British Nursing Index. To further meet its editorial purpose and reduce potential barriers to accessing published information, single copies of all published articles (in PDF or HTML format or both) are available free of charge at the WMP website (www.o-wm.com); readers are requested to register at the site without charge. There is no fee to publish in the journal, nor are there any fees associated with including figures/photographs.

All feature article submissions are peer reviewed. Because the WMP Editorial Board recognizes the importance of a timely exchange of scientific information, authors usually receive a decision about their manuscript within 3 months of submission, and most submissions are published within 6 to 9 months following receipt of the final revised manuscript.

Manuscripts that meet the WMP editorial purpose include, but are not limited to:

1) Empirical studies/original data: Includes all direct and indirect observational studies (eg, preclinical and clinical studies, meta-analyses, surveys, and studies designed to evaluate changes in practice or educational intervention outcomes). This type of manuscript typically includes an introduction/literature review, methods, results, discussion, conclusion, references, tables/figures (optional but recommended);

2) Review articles: Critical evaluation of available information about a topic, including theories, using established literature review types and methods. Includes introduction, methods, results, discussion, conclusion, references, tables/figures (optional but recommended);

3) Methodological articles: Presents new methodological approaches, including modifications of existing methods or discussions about approaches to study designs or data analysis. Includes introduction, methods, results, discussion, conclusion, references, tables/figures (optional but recommended);

4) Case studies and descriptive articles: Detailed reports of observations from working with an individual, group, community, or organization that illustrate a problem and may help inform practice or research. Includes introduction/literature review, case/patient information, discussion, conclusion, references, tables/figures (optional but recommended);

5) Brief reports: Brief reports are occasional publications of important observations that may affect patient care and outcomes, such as brief reviews of recent evidence; changes in health care policies, regulations, or reimbursement; and clinical study observations or unique clinical challenges. Includes introduction, report data, summary, and 1 small table and/or 1 or 2 clinical pictures; 

6) Opinions: Commentary on timely, important concerns relevant to the clinical, professional, regulatory, or legal arena in which readers practice. Article options include Guest Editorials, Special to Wound Management & Prevention, and Can We Talk?; and

7) Letters to the Editor: Responses to articles published in the journal. Letters are forwarded to the authors of the articles eliciting the commentary, and the original letter and the authors’ response are published.

 

All reports that involve human participants must describe Institutional Review Board (IRB) or Ethics committee approval procedures and how participants’ rights were protected and informed consent obtained. Manuscripts that do not contain this information will not be reviewed.

Studies involving animals must describe procedures used to comply with all legal and ethical requirements of the institution(s) at which, and in the jurisdictions under which, the work was done. Manuscripts that do not contain this information will not be reviewed.

Statements and opinions (including specific drug dosages) expressed in WMP are those of the authors and do not necessarily reflect those of the Editors or the Publisher. The Editors, Publisher, and the Journal deny responsibility for such materials; they do not guarantee, warrant, or endorse any product or service advertised in this publication nor guarantee any claim made by the manufacturer of such product or service. 

 

I. General Manuscript
Preparation Guidelines

WMP editorial policies for authors, reviewers, and editorial staff are based on the “Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals” published by the International Committee of Medical Journal Editors” (ICMJE; for complete guidelines, visit: www.icmje.org), the “Principles of Transparency and Best Practice in Scholarly Publishing,” and the American Medical Association (AMA) Manual of Style, 11th edition (www.amamanualofstyle.com). 

A few common concerns: All abbreviations must be spelled out when first used followed by the abbreviation in parentheses. Similarly, proprietary product name(s) and applicable copyright or trademark information should be included once in the body of the manuscript (not in the title or abstract), followed by the generic name in parentheses, which is then used throughout the remainder of the manuscript. 

Before submitting the manuscript, authors are encouraged to contact the Managing Editor by email (codyniec@hmpglobal.com). In addition, prospective authors may want to discuss their ideas with the Clinical Editor or Editorial Board members, whose names are published in every print issue and on the website. 

 

II. Preparing the Manuscript

All manuscripts follow the same general format outlined below and are based on the AMA Manual of Style guidelines. The Editors of WMP hesitate to put restrictions on word count. Manuscripts typically range from 2000 to 10 000 words, including references; the generally accepted manuscript length is 18 to 25 typewritten, double-spaced pages (not including tables and figures). Occasionally, references and tables/figures may be placed online only to conserve space in the print journal.

 

A. Authorship 

Criteria for authorship, as defined by the ICMJE and adopted by Wound Management & Prevention, include:

1) substantial contributions to conception and design, data acquisition, analysis, or interpretation; 

2) drafting the article or revising it critically for important intellectual content; and

3) final approval of the version to be published. Authors should meet conditions 1, 2, and 3.

 

All persons who meet the above criteria must be listed as authors. As part of the submission process, authors must indicate whether any writing assistance other than copy editing was provided.

Authors’ credentials, job title, and his/her facility name and location are published with the manuscript and must be provided in the submission. This information will be blinded during peer-review.

 

A.1. Student authors

WMP encourages clinicians advancing their education to submit research and/or studies undertaken during or as part of their coursework. Novice authors may request an Editorial Board member mentor to critique and guide manuscript preparation by contacting the Managing Editor. All manuscripts must conform with the journal’s style, tone, and level of scientific rigor; referencing and citations must follow AMA format (see II.J). Authors of published student manuscripts become eligible for a Student Author award, presented yearly, and free registration to one Symposium on Advanced Wound Care.

 

B. Title

The title of the manuscript should convey the topic, clinical condition, or concern and content (eg, in vivo study, randomized controlled clinical study, literature review). 

 

C. Abstract

All manuscripts should be accompanied by a structured 150- to 200-word abstract containing:

1) Background: an introductory statement about the topic and/or concern;

2) Purpose: purpose of the paper or study;

3) Methods used;

4) Results: most salient findings, results, or observations; and

5) Conclusion.

 

The abstract should be followed by 3 to 5 keywords. Authors should refer to the Medical Subject Headings (MeSH) vocabulary of the National Library of Medicine to find keywords pertaining to the type of manuscript (eg, study), health condition, and topic. Authors should visit: https://www.nlm.nih.gov/mesh/authors.html.

 

D. Introduction and/or
Literature Review

The purpose of an introduction and/or literature review for manuscripts is to describe the topic, summarize previous research and existing evidence, and identify relationships, contradictions, gaps, and inconsistencies. Summaries of previous research should use as many primary/original references and sources of information as possible. Secondary information sources (eg, review articles, textbooks) may be appropriate at times but should be identified as review articles, opinions, and the like. Throughout the manuscript, details about pertinent references used must be included to clarify the strength of existing evidence. Study type (eg, in vivo, case series), design (eg, retrospective), sample size, and summary of pertinent results must be included in the text. For example: 

“In a retrospective study by Smith et al1 of 200 patients who underwent ostomy surgery, a high healing rate (90%) was found when follow-up care was provided by a wound ostomy continence nurse.”

 

E. Study/Publication Purpose

The study/publication purpose and design or hypothesis flows from and concludes the introduction.

 

F. Methods and Procedures

All methods and procedures must be described in detail, including literature search methods for literature reviews. IRB approval and informed consent procedures used must be included for all studies involving patient interventions or use/retrieval of clinical data (see also Ethical considerations). Authors of clinical studies, especially randomized controlled tirals, should consult and follow the minimum set of recommendations for reporting the results of their work promulgated by the CONSORT group (http://www.consort-statement.org). A description of data entry and analysis methods used usually concludes the methods and procedures.

 

F.1. Case studies/descriptive articles

Case studies should follow the same format as other types of clinical studies and include a detailed description of the patient(s) and address age, sex, clinical history (eg, comorbidities, medications, confounding factors), previous treatment(s), diagnosis, current treatments, outcomes, and prognosis.

 

G. Results

All findings and results of all variables collected and analyzed are described in the text and, if appropriate, presented in tables and figures. P values  should not be reported alone in the text; numbers and percentages must be included. 

Authors should follow AMA guidelines for the use of tables and figures. Figures are usually reserved for showing data patterns. Titles and legends should provide enough detail to make illustrations comprehensible without reference to the text. 

 

H. Discussion

The discussion section evaluates and interprets the reported results and observations with respect to the study or project hypothesis or purpose. The most salient findings are highlighted while similarities and differences between the results described and previously published studies and observations are examined. Suggestions for future research to answer new or remaining questions as well as potential implications for practice should be described.

 

H1. Limitations

Limitations of the project or study (eg, small sample size, methodological limitations) are also described at the end of, or just after, the discussion section.

 

I. Conclusion

The conclusion should recap the most salient parts of the research (purpose, type of study, key participants, key findings, conclusion, and implications for practice where relevant). 

 

J. Acknowledgment (optional)

Additional contribution of human or financial resources are mentioned here. 

 

K. References

References are numbered chronologically as they appear in the text. If a reference is cited multiple times, it is noted using the number of its initial appearance. 

References are listed at the end of manuscript in the numerical order in which they appear in the text. All information needed to identify and retrieve the source must be included. For articles with more than 6 authors, list the first three authors and et al.

1. References to articles in journals, magazines, and other periodicals: Smith AA, Jones BB, Brown CC, et al. Article title: subtitle. Journal Name.  Year;volume(issue no.):page numbers. doi:XXXXXXX

2. References to book chapters: Smith AA, Jones BB, Brown CC, et al. Title of the chapter. In: Miller RR, Cohen WW, eds. Title of the Book. 3rd ed. Publisher name; Year:page numbers.

3. References to websites: Smith AA, Jones BB, Brown CC, et al. Title of the specific item cited. Name of the Website. Year published. Accessed month, day, year. URL

4. References to government/organization reports: Smith AA, Jones BB, Brown CC, et al. Name of the report. Publishing organization. Publication no. if applicable. Year published.  Accessed Month, day, year. URL

Please see AMA Manual of Style, 11th edition, for citation styles for other types of references. 

 

L. Tables and Figures

1. Patient consent requirements according to privacy practices for dissemination of health information and for all patient photographs must be met. Patient releases must be available and provided when requested by the Editors and/or as part of the manuscript submission process.

 

III. Submitting the Manuscript

A. Cover Letter 

The cover letter should provide the manuscript title as well as the corresponding author name and contact information (complete address, daytime telephone number, fax number, and email). If the manuscript contains a case study or research information, the corresponding author should explain in the cover letter how the rights and dignity of all participants involved were protected and where the information is included in the manuscript. Photographs will not be published without a signed statement of consent from the subject (or if the patient is a minor, from both parents or the legal guardian). Per the AMA Manual of Style, “photographs with black bars or other objects placed over the eyes of patients or partially obscuring part of a face should not be used in publication in print, online, video, or other multimedia.”

 

B. Disclosures 

Authors will be required to complete financial disclosure forms and copyright transfer forms as part of the submission.

1. Financial disclosure. Financial disclosures (ie, potential conflicts of interest) must be provided by all authors as part of the submission process. 

2. Studies involving animals. Authors submitting results of preclinical research should inform the Editors about methods used to adhere to animal welfare regulations.

 

C. Revisions

If a manuscript has been accepted with revisions, authors will be asked to return the revised manuscript within 4 to 6 weeks. If the authors cannot meet the specified deadline, an extension can be requested. Only requested revisions should be made. Revised manuscripts with changes not requested by the reviewers (eg, new data or information, changes in conclusion/interpretation of findings) will not be accepted and will be returned to the authors.

 

IV. Submission Criteria/Ethical and 

Legal Considerations

A. Copyrights

In accordance with the AMA, American Psychological Association, and ICMJE guidelines, duplicate or redundant publication of manuscripts is generally unacceptable. Failure to disclose the existence of duplicate articles, manuscripts, or other material is unethical and may represent a violation of copyright law. Exceptions to this rule, providing proper attribution to the report or disclosure of presentation is provided, may include summaries or abstracts of findings printed in conference proceedings, short reports of author findings distributed at meetings, reports from government documents or reports in the public domain, and translation of reports in another language. Material directly quoted from previously published work can be incorporated in a short quotation (with appropriate attribution). Approval from the copyright holder (institution, publisher, or author) to use more than 40 words or any tables, figures, and photographs from previously published work must be obtained in writing and provided to the Editors. Manuscripts submitted to WMP are reviewed and accepted with the understanding that they have not been previously published and are not submitted for review elsewhere. 

Upon submission of the manuscript, authors will be asked to confirm that the manuscript is original and does not contain substantial amounts of information or data that have been published elsewhere or have been submitted for review and publication elsewhere. The author(s) also will be asked to accept copyright transfer in the event that the article would be published. Manuscripts accepted for publication are copyrighted in the volume and issue in which they are published. Although HMP Global holds the copyright, no fee is assessed for the author to use/have access to the article for noncommercial/educational purposes. 

Following publication of the manuscript, US-based authors will receive 5 complimentary copies of the issue in which his/her article appears. All authors receive a PDF of the published article. Authors receive a discount when ordering reprints of their publications.

Note: the sending of complimentary copies has been suspended due to the COVID-19 pandemic. However, all authors still receive a PDF of their article. 

 

B. Errors and Misconduct

If an author identifies an error after the manuscript has been published, he/she must contact the Managing Editor as soon as possible and prepare a letter correcting the error(s) for publication in the Journal. The Editorial Policy Committee of the Council of Science Editors has identified the following general areas of research misconduct: 

1) unethical treatment of research subjects; 

2) fabrication of data; 

3) falsification of data; and

4) plagiarism. Plagiarism includes the use of another person’s ideas, processes, results, or words without giving appropriate credit. 

If the editors become aware of research misconduct after a manuscript has been published, the editors will contact the authors and notify the readers.

 

V. Submission Process

WMP will work with the corresponding author,  who will be responsible for all correspondence regarding submission, review, revision, and acceptance. It is the responsibility of the corresponding author to ensure all deadlines are met and all documents are distributed to additional authors and returned promptly. It is also the author’s responsibility to keep the Editors abreast of his/her reliable contact information.

 

A. Sending the Manuscript/Materials

All manuscript materials are to be submitted using the online Editorial Manager system at: www.edmgr.com/OWM/default.aspx. Authors should select the Author option and follow the online instructions found on this website for uploading the manuscript and all related material. 

Tables and figures should be labeled per their citations in text in numeric order and should be labeled clearly. Tables and figures should not be embedded within the text of the Word document submitted; they should appear at the end of the manuscript. Separate JPG files should be submitted for each figure. All photographs must comply with current HIPAA regulations protecting patient identity.

Persons without access to the internet should contact the Editor directly for instructions on hard-copy submission.    

Christiane Odyniec, Managing Editor

Wound Management & Prevention 

HMP Global

70 E. Swedesford Road, Suite 100

Malvern, PA 19355

(800) 237-7285, ext. 4268

(610) 560-0500, ext. 4268

Email: codyniec@hmpglobal.com

 

VI. Manuscript Review and 

 Publication ProcessES

Manuscripts that are not relevant to the focus of the Journal and/or that do not meet the standards outlined in this document will be returned to the author without review. The Managing Editor reserves the right to limit the number of articles on a given topic. 

All other submitted manuscripts go through at least two (2) review cycles. During the first cycle, the manuscript undergoes peer review. This process is double-blinded; the identity of the author(s) is not revealed to the reviewers and vice versa. Manuscripts are reviewed for accuracy, completeness, concordance with above-mentioned requirements, contribution to new knowledge, relevance to the focus of the journal, timeliness, and originality. This part of the review process takes approximately 3 months. At the end of this period, the corresponding author will receive a letter indicating either rejection or possible acceptance of the manuscript, contingent on the authors’ responses to reviewers’ comments and requests for revision. The author will have 4 to 8 weeks to revise the manuscript, depending on the level of writing and editing required. Extensions can be requested through the Managing Editor. 

If the author chooses to revise the manuscript and submit a revision through Editorial Manager, the second review cycle begins. This involves verification that requested revisions have been made, review by the Clinical Editor, and copy editing. The manuscript is then returned to the author for final corrections/editing. After this  is complete, the manuscript is scheduled for publication. 

The author will receive a PDF of the article, as it will appear in print, for final review. The author will be required to review this document in 24 to 72 hours. ν

Resources

1. American Medical Association. AMA Manual of Style: A Guide for Authors and Editors. 11th ed. Oxford University Press; 2019.

2. American Psychological Association. Publication Manual of the American Psychological Association. 7th ed, American Psychological Association; 2020.

3. CONSORT. The CONSORT Statement. CONSORT: The Transparent Reporting of Trials. 2010. Accessed April 26, 2021. http://www.consort-statement.org/consort-2010 

4. International Committee of Medical Journal Editors. Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals.  ICMJE; 2019. Accessed April 26, 2021. http://www.icmje.org/icmje-recommendations.pdf 

5. Editorial Policy Committee Council of Science Editors. CSE’s White Paper on Promoting Integrity in Scientific Journal Publications.  Council of Science Editors; 2018. Accessed April 26, 2021. www.councilscienceeditors.org/wp-content/uploads/CSE-White-Paper_2018-